This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Bloomberg News
bloomberg.com
did:plc:uewxgchsjy4kmtu7dcxa77us
Revolution Medicines secured US regulatory approval for its pancreatic cancer drug daraxonrasib, the first medicine to target one of the key molecular causes of the disease.
https://bloom.bg/3UBjKyU
2026-08-26T15:30:17.376Z